Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Sky One Medical Ups Q1 Revenue by 30%

publication date: Jun 6, 2007
Profits Increase 74% -- China Sky One Medical Inc. (Bulletin Board: CSKI), which produces and distributes Western medicines for sale in China, reported solid increases on its year-over-year financial results for the first quarter of 2007. Revenues jumped 30% to $5.2 million while profits soared 74% to $1.5 million, which works out to $0.12 per share. Gross margin also moved up, rising to 78.2% from 76.1%. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital